FCX vs ORMP
Freeport-McMoran Copper & Gold Inc (FCX) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Freeport-McMoran Copper & Gold Inc (FCX) is a copper company listed on US.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported FCX revenue for 2024-12-31 was $25.45B. Net income was $4.40B. Revenue was up 11.4% from 2023-12-31 to 2024-12-31. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
FCX currently screens at market cap $67.80B and trailing P/E 38.0. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the FCX and ORMP stock pages for the full models.
Not investment advice.